Evidence map›Paper›PMID 41128522›Full record

ArticlemBio2025

Modulation of the

Andrew Frando, Robert S Parsek, Jamal Omar, Marie-Christine Groleau, Mylène C Trottier, Nicole E Smalley, Eric Déziel, Ajai A Dandekar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Inactivation of MexT inJournal of bacteriology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Andrew FrandoDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-3476-1345
Robert S ParsekDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Jamal OmarDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Marie-Christine GroleauCentre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, Québec, Canada.ORCID 0000-0003-4810-1030
Mylène C TrottierCentre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, Québec, Canada.ORCID 0009-0002-5849-5686
Nicole E SmalleyDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-3863-4335
Eric DézielCentre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, Québec, Canada.ORCID 0000-0002-4609-0115
Ajai A DandekarDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2992-6523

Funding

ACADEMIC PEDIATRIC INFECTIOUS DISEASET32HD007233 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI KEVIN B URDAHL · 1985 to 2026
$6.7M
Quinolone and acyl-homoserine lactone quorum sensing in chronic P. aeruginosa infectionsR01AI177575 · NIAID · UNIVERSITY OF WASHINGTON · PI Ajai Dandekar · 2023 to 2026
$1.8M
CIHR 508306Cystic Fibrosis Foundation FRANDO24F0NIAID NIH HHS R01 AI177575NICHD NIH HHS T32 HD007233
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial ProteinsGene Expression Regulation, BacterialPseudomonas aeruginosaQuorum SensingTranscription FactorsOperonRegulonTrans-ActivatorsBacterial ProteinsLasR protein, Pseudomonas aeruginosaTrans-ActivatorsTranscription FactorseffluxLasRPqsRRhlR

Identifiers

PMID41128522
PMCPMC12607905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.